Last Updated: May 3, 2026

Yung Shin Pharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for YUNG SHIN PHARM

YUNG SHIN PHARM has eleven approved drugs.



Summary for Yung Shin Pharm
US Patents:0
Tradenames:9
Ingredients:9
NDAs:11

Drugs and US Patents for Yung Shin Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yung Shin Pharm CEFACLOR cefaclor FOR SUSPENSION;ORAL 065412-001 Feb 17, 2012 RX No No ⤷  Start Trial ⤷  Start Trial
Yung Shin Pharm ENTECAVIR entecavir TABLET;ORAL 208195-002 Nov 10, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial
Yung Shin Pharm ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 077990-002 Apr 23, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial
Yung Shin Pharm GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 202647-001 Mar 6, 2020 DISCN No No ⤷  Start Trial ⤷  Start Trial
Yung Shin Pharm DICLOFENAC SODIUM AND MISOPROSTOL diclofenac sodium; misoprostol TABLET, DELAYED RELEASE;ORAL 205143-001 Feb 19, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial
Yung Shin Pharm GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 202648-002 Jun 29, 2020 DISCN No No ⤷  Start Trial ⤷  Start Trial
Yung Shin Pharm CEFACLOR cefaclor CAPSULE;ORAL 065146-002 Jan 22, 2004 RX No Yes ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.